Tin tức & Cập nhật
Xem bài viết Tim mạch
Xem
Methotrexate may lower CV risk in psoriasis patients
Patients with psoriasis who are treated with methotrexate (MTX) show a reduced incidence of metabolic syndrome and better cardiometabolic profiles, according to a study presented at AAD 2026.
Methotrexate may lower CV risk in psoriasis patients
17 Apr 2026
ICLAD predicts poor vascular outcomes after ischaemic stroke
The presence of intracranial large artery disease (ICLAD) is associated with poor composite vascular outcomes, myocardial infarction (MI), and vascular death, but not recurrence, in patients with acute ischaemic stroke, suggests a Singapore study.
ICLAD predicts poor vascular outcomes after ischaemic stroke
16 Apr 2026
Mavacamten reduces blood flow obstruction in adolescents with HCM
Treatment with mavacamten, compared with placebo, results in significantly greater reduction in left ventricular outflow tract (LVOT) obstruction over 28 weeks among adolescent patients with obstructive hypertrophic cardiomyopathy (HCM), as shown in the SCOUT-HCM trial.
Mavacamten reduces blood flow obstruction in adolescents with HCM
14 Apr 2026
More aggressive LDL-C reduction improves cardiac outcomes in ASCVD patients
An intensive targeting of low-density lipoprotein cholesterol (LDL-C) level (<55 mg/dL) reduces the risk of cardiovascular events at 3 years in patients with atherosclerotic cardiovascular disease (ASCVD) when compared with conventional targeting (<70 mg/dL), results of the Ez-PAVE trial have shown.